---
schema_version: "secwatch.filing_event.v1"
accession: "0001724521-25-000078"
form_type: "8-K"
ticker: "RCUS"
cik: "0001724521"
company_name: "Arcus Biosciences, Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:52:47.073294+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Arcus annual meeting elects directors, ratifies E&Y, approves say-on-pay; board revises director comp

## Summary
- All four Class I director nominees elected with >86M votes each (broker non-votes ~8.6M).
- Ernst & Young ratified as auditor for FY2025 with 96.8M votes for (96.3% of votes cast).
- Advisory 'say-on-pay' approved with 84.8M for (93.9% of votes cast excluding abstentions).
- Board revised Non-Employee Director Compensation Program: $50k cash retainer, $750k initial equity, $400k annual equity.

## SEC filing metadata
- accession: 0001724521-25-000078
- form_type: 8-K
- ticker: RCUS
- cik: 0001724521
- company_name: Arcus Biosciences, Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1724521/000172452125000078/0001724521-25-000078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1724521/000172452125000078/rcus-20250610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001724521-25-000078
- JSON: https://secwatch.observer/filing/0001724521-25-000078.json
- Plain text: https://secwatch.observer/filing/0001724521-25-000078.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.